IL17A and psoriasis: We recently used RT-PCR analyses of total skin from a randomized placebo-controlled clinical trial (ClinicalTrial.gov identifier: NCT03131570) to study psoriasis skin transcriptome modifications induced by systemic IL-17A blockade (10).